At Bright Peak we are using our world-class protein engineering capabilities to create the next-generation of multifunctional precision immunotherapies.
Using our proprietary chemical protein synthesis platform, we are developing an emerging portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune diseases.
'